Medical Inhaled Nitric Oxide Market Report – Research, Industry Analysis Reports and Market Demands

Global Medical Inhaled Nitric Oxide Supply, Demand and Key Producers, 2026-2032

Request for Sample of this report

Buy now

Table of Content

1 Supply Summary

1.1 Medical Inhaled Nitric Oxide Introduction
1.2 World Medical Inhaled Nitric Oxide Supply & Forecast
- 1.2.1 World Medical Inhaled Nitric Oxide Production Value (2021 & 2025 & 2032)
- 1.2.2 World Medical Inhaled Nitric Oxide Production (2021-2032)
- 1.2.3 World Medical Inhaled Nitric Oxide Pricing Trends (2021-2032)
1.3 World Medical Inhaled Nitric Oxide Production by Region (Based on Production Site)
- 1.3.1 World Medical Inhaled Nitric Oxide Production Value by Region (2021-2032)
- 1.3.2 World Medical Inhaled Nitric Oxide Production by Region (2021-2032)
- 1.3.3 World Medical Inhaled Nitric Oxide Average Price by Region (2021-2032)
- 1.3.4 North America Medical Inhaled Nitric Oxide Production (2021-2032)
- 1.3.5 Europe Medical Inhaled Nitric Oxide Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
- 1.4.1 Medical Inhaled Nitric Oxide Market Drivers
- 1.4.2 Factors Affecting Demand
- 1.4.3 Medical Inhaled Nitric Oxide Major Market Trends

2 Demand Summary

2.1 World Medical Inhaled Nitric Oxide Demand (2021-2032)
2.2 World Medical Inhaled Nitric Oxide Consumption by Region
- 2.2.1 World Medical Inhaled Nitric Oxide Consumption by Region (2021-2026)
- 2.2.2 World Medical Inhaled Nitric Oxide Consumption Forecast by Region (2027-2032)
2.3 United States Medical Inhaled Nitric Oxide Consumption (2021-2032)
2.4 China Medical Inhaled Nitric Oxide Consumption (2021-2032)
2.5 Europe Medical Inhaled Nitric Oxide Consumption (2021-2032)
2.6 Japan Medical Inhaled Nitric Oxide Consumption (2021-2032)
2.7 South Korea Medical Inhaled Nitric Oxide Consumption (2021-2032)
2.8 ASEAN Medical Inhaled Nitric Oxide Consumption (2021-2032)
2.9 India Medical Inhaled Nitric Oxide Consumption (2021-2032)

3 World Manufacturers Competitive Analysis

3.1 World Medical Inhaled Nitric Oxide Production Value by Manufacturer (2021-2026)
3.2 World Medical Inhaled Nitric Oxide Production by Manufacturer (2021-2026)
3.3 World Medical Inhaled Nitric Oxide Average Price by Manufacturer (2021-2026)
3.4 Medical Inhaled Nitric Oxide Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
- 3.5.1 Global Medical Inhaled Nitric Oxide Industry Rank of Major Manufacturers
- 3.5.2 Global Concentration Ratios (CR4) for Medical Inhaled Nitric Oxide in 2025
- 3.5.3 Global Concentration Ratios (CR8) for Medical Inhaled Nitric Oxide in 2025
3.6 Medical Inhaled Nitric Oxide Market: Overall Company Footprint Analysis
- 3.6.1 Medical Inhaled Nitric Oxide Market: Region Footprint
- 3.6.2 Medical Inhaled Nitric Oxide Market: Company Product Type Footprint
- 3.6.3 Medical Inhaled Nitric Oxide Market: Company Product Application Footprint
3.7 Competitive Environment
- 3.7.1 Historical Structure of the Industry
- 3.7.2 Barriers of Market Entry
- 3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World

5 Market Analysis by NO Concentration

5.1 World Medical Inhaled Nitric Oxide Market Size Overview by NO Concentration: 2021 VS 2025 VS 2032
5.2 Segment Introduction by NO Concentration
- 5.2.1 High Purity iNO
- 5.2.2 Standard Purity iNO
5.3 Market Segment by NO Concentration
- 5.3.1 World Medical Inhaled Nitric Oxide Production by NO Concentration (2021-2032)
- 5.3.2 World Medical Inhaled Nitric Oxide Production Value by NO Concentration (2021-2032)
- 5.3.3 World Medical Inhaled Nitric Oxide Average Price by NO Concentration (2021-2032)

6 Market Analysis by Application

6.1 World Medical Inhaled Nitric Oxide Market Size Overview by Application: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Application
- 6.2.1 Infants PPHN
- 6.2.2 ARDS, etc.
6.3 Market Segment by Application
- 6.3.1 World Medical Inhaled Nitric Oxide Production by Application (2021-2032)
- 6.3.2 World Medical Inhaled Nitric Oxide Production Value by Application (2021-2032)
- 6.3.3 World Medical Inhaled Nitric Oxide Average Price by Application (2021-2032)

7 Company Profiles

7.1 Mallinckrodt (INOmax)
- 7.1.1 Mallinckrodt (INOmax) Details
- 7.1.2 Mallinckrodt (INOmax) Major Business
- 7.1.3 Mallinckrodt (INOmax) Medical Inhaled Nitric Oxide Product and Services
- 7.1.4 Mallinckrodt (INOmax) Medical Inhaled Nitric Oxide Production, Price, Value, Gross Margin and Market Share (2021-2026)
- 7.1.5 Mallinckrodt (INOmax) Recent Developments/Updates
- 7.1.6 Mallinckrodt (INOmax) Competitive Strengths & Weaknesses
7.2 Linde (Noxivent)
- 7.2.1 Linde (Noxivent) Details
- 7.2.2 Linde (Noxivent) Major Business
- 7.2.3 Linde (Noxivent) Medical Inhaled Nitric Oxide Product and Services
- 7.2.4 Linde (Noxivent) Medical Inhaled Nitric Oxide Production, Price, Value, Gross Margin and Market Share (2021-2026)
- 7.2.5 Linde (Noxivent) Recent Developments/Updates
- 7.2.6 Linde (Noxivent) Competitive Strengths & Weaknesses
7.3 Air Liquide (KINOX)
- 7.3.1 Air Liquide (KINOX) Details
- 7.3.2 Air Liquide (KINOX) Major Business
- 7.3.3 Air Liquide (KINOX) Medical Inhaled Nitric Oxide Product and Services
- 7.3.4 Air Liquide (KINOX) Medical Inhaled Nitric Oxide Production, Price, Value, Gross Margin and Market Share (2021-2026)
- 7.3.5 Air Liquide (KINOX) Recent Developments/Updates
- 7.3.6 Air Liquide (KINOX) Competitive Strengths & Weaknesses

8 Industry Chain Analysis

8.1 Medical Inhaled Nitric Oxide Industry Chain
8.2 Medical Inhaled Nitric Oxide Upstream Analysis
- 8.2.1 Medical Inhaled Nitric Oxide Core Raw Materials
- 8.2.2 Main Manufacturers of Medical Inhaled Nitric Oxide Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Medical Inhaled Nitric Oxide Production Mode
8.6 Medical Inhaled Nitric Oxide Procurement Model
8.7 Medical Inhaled Nitric Oxide Industry Sales Model and Sales Channels
- 8.7.1 Medical Inhaled Nitric Oxide Sales Model
- 8.7.2 Medical Inhaled Nitric Oxide Typical Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Methodology
10.2 Research Process and Data Source

Description

The global Medical Inhaled Nitric Oxide market size is expected to reach $ 1006 million by 2032, rising at a market growth of 5.9% CAGR during the forecast period (2026-2032).
Inhaled Nitric Oxide (iNO) therapy is a medical treatment involving the inhalation of nitric oxide gas, primarily used to treat conditions such as Acute Respiratory Distress Syndrome (ARDS), pulmonary hypertension, and neonatal pulmonary hypertension. As a gas-based therapy, iNO works by relaxing the smooth muscles of the pulmonary blood vessels, reducing pulmonary vascular resistance, and thereby improving oxygenation and reducing the load on the lungs and heart. iNO is most commonly used in intensive care units (ICUs), particularly for critically ill neonates and adults. Compared to traditional pharmacological treatments, iNO offers a more precise way to regulate blood flow and oxygen supply to the lungs, with fewer side effects. The therapy is delivered through specialized devices, such as inhaled nitric oxide therapy systems, portable inhalation devices, and other apparatus designed to deliver controlled amounts of nitric oxide directly to patients. These devices typically include real-time monitoring of nitric oxide concentration, oxygen levels, and gas flow rates, ensuring precise and safe treatment.
The product range for medical inhaled nitric oxide includes large ICU systems, portable systems, and home-care systems. With advancements in technology, there is an increasing demand for more efficient and user-friendly devices, especially in home-care settings. Portable nitric oxide therapy systems have become particularly important for neonates and adults with chronic conditions, offering both acute and long-term therapeutic benefits. As such, iNO therapy plays an essential role not only in emergency care but also in ongoing treatment for patients with complex respiratory issues.
The medical inhaled nitric oxide (iNO) market is experiencing rapid growth, driven by multiple factors. First, the rising incidence of chronic respiratory diseases and Acute Respiratory Distress Syndrome (ARDS) has significantly increased the demand for iNO therapy. With the aging global population and the high prevalence of lung and cardiovascular diseases, iNO has become an essential treatment option. Particularly in neonatal intensive care, iNO is widely used to treat conditions such as neonatal pulmonary hypertension. Second, with advancements in medical technology, iNO devices are becoming more compact and portable, increasing the accessibility of iNO therapy outside of hospital settings. This shift has opened up vast opportunities for home care and telemedicine solutions, expanding the market.
However, there are risks and challenges in the market. First, the high cost of iNO therapy equipment presents a significant barrier, particularly for healthcare institutions in developing countries. Second, the use of iNO requires specialized equipment and expertise, leading to a need for extensive training for healthcare providers. Furthermore, prolonged use of iNO may lead to potential side effects, such as damage to the lungs or other organs due to high concentrations of nitrogen oxides, necessitating strict monitoring during therapy. The market is also highly concentrated, with a few major players dominating, which could potentially lead to market imbalances in terms of competition.
With ongoing advancements in technology, the performance and reliability of iNO devices continue to improve. Emerging technological trends include more precise gas delivery systems, integrated smart monitoring features, and the development of user-friendly home therapy systems. In the future, the integration of artificial intelligence and big data into iNO therapy could lead to more personalized and intelligent treatment solutions, marking a new direction in the market's evolution.
This report studies the global Medical Inhaled Nitric Oxide production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Medical Inhaled Nitric Oxide and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Medical Inhaled Nitric Oxide that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Medical Inhaled Nitric Oxide total production and demand, 2021-2032, (Million L)
Global Medical Inhaled Nitric Oxide total production value, 2021-2032, (USD Million)
Global Medical Inhaled Nitric Oxide production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Million L), (based on production site)
Global Medical Inhaled Nitric Oxide consumption by region & country, CAGR, 2021-2032 & (Million L)
U.S. VS China: Medical Inhaled Nitric Oxide domestic production, consumption, key domestic manufacturers and share
Global Medical Inhaled Nitric Oxide production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Million L)
Global Medical Inhaled Nitric Oxide production by NO Concentration, production, value, CAGR, 2021-2032, (USD Million) & (Million L)
Global Medical Inhaled Nitric Oxide production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Million L)
This report profiles key players in the global Medical Inhaled Nitric Oxide market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Mallinckrodt (INOmax), Linde (Noxivent), Air Liquide (KINOX), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Medical Inhaled Nitric Oxide market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Million L) and average price (USD/L) by manufacturer, by NO Concentration, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Medical Inhaled Nitric Oxide Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Medical Inhaled Nitric Oxide Market, Segmentation by NO Concentration:
High Purity iNO
Standard Purity iNO
Global Medical Inhaled Nitric Oxide Market, Segmentation by Application:
Infants PPHN
ARDS, etc.
Companies Profiled:
Mallinckrodt (INOmax)
Linde (Noxivent)
Air Liquide (KINOX)
Key Questions Answered:
1. How big is the global Medical Inhaled Nitric Oxide market?
2. What is the demand of the global Medical Inhaled Nitric Oxide market?
3. What is the year over year growth of the global Medical Inhaled Nitric Oxide market?
4. What is the production and production value of the global Medical Inhaled Nitric Oxide market?
5. Who are the key producers in the global Medical Inhaled Nitric Oxide market?
6. What are the growth factors driving the market demand?

Buy now